Arcturus Therapeutics Holdings (ARCT) Net Cash Flow Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) Net Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 301.06% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - | 3.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.43% |
| Dec 31, 2025 | -2,867.33% |
| Sep 30, 2025 | 30.43% |
| Jun 30, 2025 | 27.03% |
| Mar 31, 2025 | -456.39% |
| Dec 31, 2024 | 99.26% |
| Sep 30, 2024 | -100.49% |
| Jun 30, 2024 | -155.53% |
| Mar 31, 2024 | 94.35% |
| Dec 31, 2023 | -113.07% |
| Sep 30, 2023 | 74.79% |
| Jun 30, 2023 | 239.69% |
| Mar 31, 2023 | -25.80% |
| Dec 31, 2022 | 455.47% |
| Sep 30, 2022 | -158.43% |
| Jun 30, 2022 | -8.78% |
| Mar 31, 2022 | -1,388.39% |
| Dec 31, 2021 | -127.83% |
| Sep 30, 2021 | -110.37% |
| Jun 30, 2021 | -143.40% |